Group One Trading
FPRX

Group One Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Group One Trading’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-42,100
Closed -$1.59M – 8870
2021
Q1 		$1.59M Buy
42,100
+27,200
+183% +$678K ﹤0.01% 2717
2020
Q4 		$253K Buy
14,900
+11,900
+397% +$149K ﹤0.01% 3885
2020
Q3 		$14K Sell
3,000
-12,200
-80% -$62K ﹤0.01% 5303
2020
Q2 		$93K Buy
+15,200
New +$62.6K ﹤0.01% 3968
2017
Q4 		– Sell
-9,000
Closed -$368K – 5423
2017
Q3 		$368K Buy
9,000
+8,500
+1,700% +$267K ﹤0.01% 2321
2017
Q2 		$15K Buy
+500
New +$15.6K ﹤0.01% 4064
2016
Q2 		– Sell
-300
Closed -$12K – 5082
2016
Q1 		$12K Buy
300
+200
+200% +$6.87K ﹤0.01% 3964
2015
Q4 		$4K Sell
100
-100
-50% -$3.35K ﹤0.01% 4437
2015
Q3 		$3K Buy
200
+100
+100% +$2.15K ﹤0.01% 4647
2015
Q2 		$2K Buy
+100
New +$2.23K ﹤0.01% 4699

Group One Trading's FPRX Position: Q1 2021 in Review

Group One Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 4,786 shares — an estimated $119K sold.

Group One Trading first reported a position in FPRX in Q4 2015 and held it in 10 quarters. The position peaked at $363K in Q2 2018. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Group One Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 4,786 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $119K.
  • Group One Trading first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 10 quarters.
  • Group One Trading's Five Prime Therapeutics, Inc. position peaked at $363K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.